nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—CYP2C9—Capecitabine—colon cancer	0.0651	0.321	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Fluorouracil—colon cancer	0.0553	0.273	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Fluorouracil—colon cancer	0.0386	0.19	CbGbCtD
Medroxyprogesterone Acetate—AR—scrotum—colon cancer	0.0326	0.213	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Irinotecan—colon cancer	0.0234	0.115	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Vincristine—colon cancer	0.0204	0.101	CbGbCtD
Medroxyprogesterone Acetate—AKR1C3—Vinblastine—Vincristine—colon cancer	0.00878	1	CbGdCrCtD
Medroxyprogesterone Acetate—HSD3B2—digestive system—colon cancer	0.00863	0.0564	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—colon cancer	0.00666	0.0436	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—colon cancer	0.00521	0.0341	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—colon cancer	0.00493	0.0322	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—smooth muscle tissue—colon cancer	0.00461	0.0302	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—bone marrow—colon cancer	0.00336	0.022	CbGeAlD
Medroxyprogesterone Acetate—PGR—epithelium—colon cancer	0.00324	0.0212	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—vagina—colon cancer	0.00322	0.021	CbGeAlD
Medroxyprogesterone Acetate—PGR—smooth muscle tissue—colon cancer	0.00312	0.0204	CbGeAlD
Medroxyprogesterone Acetate—ESR1—embryo—colon cancer	0.00311	0.0203	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—liver—colon cancer	0.00271	0.0177	CbGeAlD
Medroxyprogesterone Acetate—AR—epithelium—colon cancer	0.00258	0.0169	CbGeAlD
Medroxyprogesterone Acetate—ESR1—epithelium—colon cancer	0.00253	0.0166	CbGeAlD
Medroxyprogesterone Acetate—SHBG—bone marrow—colon cancer	0.00252	0.0165	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymphoid tissue—colon cancer	0.0025	0.0163	CbGeAlD
Medroxyprogesterone Acetate—AR—smooth muscle tissue—colon cancer	0.00249	0.0163	CbGeAlD
Medroxyprogesterone Acetate—ESR1—smooth muscle tissue—colon cancer	0.00244	0.016	CbGeAlD
Medroxyprogesterone Acetate—SHBG—vagina—colon cancer	0.00242	0.0158	CbGeAlD
Medroxyprogesterone Acetate—AR—renal system—colon cancer	0.00239	0.0157	CbGeAlD
Medroxyprogesterone Acetate—ESR1—renal system—colon cancer	0.00235	0.0154	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—embryo—colon cancer	0.00229	0.015	CbGeAlD
Medroxyprogesterone Acetate—PGR—vagina—colon cancer	0.00218	0.0142	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lymph node—colon cancer	0.00208	0.0136	CbGeAlD
Medroxyprogesterone Acetate—SHBG—liver—colon cancer	0.00204	0.0133	CbGeAlD
Medroxyprogesterone Acetate—AR—lymphoid tissue—colon cancer	0.00199	0.013	CbGeAlD
Medroxyprogesterone Acetate—AR—digestive system—colon cancer	0.00196	0.0128	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymphoid tissue—colon cancer	0.00195	0.0128	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—renal system—colon cancer	0.00194	0.0127	CbGeAlD
Medroxyprogesterone Acetate—ESR1—digestive system—colon cancer	0.00193	0.0126	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—epithelium—colon cancer	0.00187	0.0122	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—smooth muscle tissue—colon cancer	0.0018	0.0118	CbGeAlD
Medroxyprogesterone Acetate—AR—vagina—colon cancer	0.00173	0.0113	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—renal system—colon cancer	0.00173	0.0113	CbGeAlD
Medroxyprogesterone Acetate—ESR1—vagina—colon cancer	0.0017	0.0111	CbGeAlD
Medroxyprogesterone Acetate—AR—liver—colon cancer	0.00146	0.00957	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymphoid tissue—colon cancer	0.00144	0.00942	CbGeAlD
Medroxyprogesterone Acetate—ESR1—liver—colon cancer	0.00144	0.0094	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—digestive system—colon cancer	0.00142	0.00931	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—digestive system—colon cancer	0.00141	0.00923	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymph node—colon cancer	0.00141	0.00921	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—vagina—colon cancer	0.0014	0.00918	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—renal system—colon cancer	0.00131	0.00858	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—bone marrow—colon cancer	0.00131	0.00858	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—vagina—colon cancer	0.00126	0.00822	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—liver—colon cancer	0.00118	0.00774	CbGeAlD
Medroxyprogesterone Acetate—AR—lymph node—colon cancer	0.00112	0.00734	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymph node—colon cancer	0.0011	0.0072	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—digestive system—colon cancer	0.00108	0.00704	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—liver—colon cancer	0.00106	0.00693	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—liver—colon cancer	0.00105	0.00688	CbGeAlD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—colon cancer	0.000864	0.229	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—ABCB1—colon cancer	0.000841	0.223	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—lymph node—colon cancer	0.000813	0.00532	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—liver—colon cancer	0.000802	0.00524	CbGeAlD
Medroxyprogesterone Acetate—Methylprednisolone—ABCB1—colon cancer	0.000644	0.171	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—ABCB1—colon cancer	0.000523	0.139	CrCbGaD
Medroxyprogesterone Acetate—Infection—Vincristine—colon cancer	0.000494	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Capecitabine—colon cancer	0.000494	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Fluorouracil—colon cancer	0.000492	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Methotrexate—colon cancer	0.000491	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Irinotecan—colon cancer	0.000488	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Vincristine—colon cancer	0.000488	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Vincristine—colon cancer	0.000487	0.0011	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Irinotecan—colon cancer	0.000484	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Irinotecan—colon cancer	0.000484	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Fluorouracil—colon cancer	0.000484	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Fluorouracil—colon cancer	0.000484	0.00109	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Irinotecan—colon cancer	0.000481	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Vincristine—colon cancer	0.000481	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Capecitabine—colon cancer	0.000481	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Capecitabine—colon cancer	0.000479	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Fluorouracil—colon cancer	0.000478	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Irinotecan—colon cancer	0.000476	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Irinotecan—colon cancer	0.000475	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Irinotecan—colon cancer	0.000474	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Vincristine—colon cancer	0.000474	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Methotrexate—colon cancer	0.000469	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Irinotecan—colon cancer	0.000468	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Fluorouracil—colon cancer	0.000468	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Methotrexate—colon cancer	0.000465	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Vincristine—colon cancer	0.000465	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Capecitabine—colon cancer	0.000464	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Fluorouracil—colon cancer	0.000464	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Fluorouracil—colon cancer	0.000464	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Irinotecan—colon cancer	0.000462	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Methotrexate—colon cancer	0.000462	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Fluorouracil—colon cancer	0.000461	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Capecitabine—colon cancer	0.000458	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Capecitabine—colon cancer	0.000456	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Capecitabine—colon cancer	0.000456	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Fluorouracil—colon cancer	0.000455	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Fluorouracil—colon cancer	0.000454	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000453	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Capecitabine—colon cancer	0.000453	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Fluorouracil—colon cancer	0.000453	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Irinotecan—colon cancer	0.000452	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Capecitabine—colon cancer	0.00045	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Vincristine—colon cancer	0.00045	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Capecitabine—colon cancer	0.000449	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Capecitabine—colon cancer	0.000448	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Capecitabine—colon cancer	0.000447	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Vincristine—colon cancer	0.000446	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Methotrexate—colon cancer	0.000444	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Fluorouracil—colon cancer	0.000442	0.000996	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Capecitabine—colon cancer	0.00044	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Irinotecan—colon cancer	0.000438	0.000987	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Irinotecan—colon cancer	0.000435	0.00098	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Fluorouracil—colon cancer	0.000433	0.000977	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Vincristine—colon cancer	0.000432	0.000974	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Irinotecan—colon cancer	0.000432	0.000973	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Capecitabine—colon cancer	0.000431	0.000972	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Irinotecan—colon cancer	0.00043	0.00097	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Vincristine—colon cancer	0.000429	0.000967	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Vincristine—colon cancer	0.000429	0.000966	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Capecitabine—colon cancer	0.000426	0.000961	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Irinotecan—colon cancer	0.000426	0.000961	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Capecitabine—colon cancer	0.000425	0.000959	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Vincristine—colon cancer	0.000425	0.000958	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Methotrexate—colon cancer	0.000424	0.000956	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Capecitabine—colon cancer	0.000423	0.000954	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000423	0.000952	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Irinotecan—colon cancer	0.000421	0.000949	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Fluorouracil—colon cancer	0.000419	0.000945	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Irinotecan—colon cancer	0.000418	0.000942	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Irinotecan—colon cancer	0.000417	0.000941	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Fluorouracil—colon cancer	0.000416	0.000939	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Irinotecan—colon cancer	0.000414	0.000933	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Capecitabine—colon cancer	0.000414	0.000933	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Fluorouracil—colon cancer	0.000413	0.000932	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Fluorouracil—colon cancer	0.000412	0.000929	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Capecitabine—colon cancer	0.000412	0.000929	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Capecitabine—colon cancer	0.000411	0.000927	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Capecitabine—colon cancer	0.000409	0.000922	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Fluorouracil—colon cancer	0.000408	0.00092	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Methotrexate—colon cancer	0.000407	0.000917	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Vincristine—colon cancer	0.000407	0.000916	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Fluorouracil—colon cancer	0.000403	0.000909	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Capecitabine—colon cancer	0.000403	0.000908	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0004	0.000902	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Capecitabine—colon cancer	0.0004	0.000901	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Irinotecan—colon cancer	0.000399	0.000899	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Capecitabine—colon cancer	0.000397	0.000895	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Capecitabine—colon cancer	0.000397	0.000895	CcSEcCtD
Medroxyprogesterone Acetate—Dysuria—Methotrexate—colon cancer	0.000397	0.000894	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Irinotecan—colon cancer	0.000396	0.000892	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Methotrexate—colon cancer	0.000394	0.000889	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Vincristine—colon cancer	0.000393	0.000886	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Vincristine—colon cancer	0.000393	0.000886	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Capecitabine—colon cancer	0.000391	0.000882	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Capecitabine—colon cancer	0.000389	0.000876	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Capecitabine—colon cancer	0.000384	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Irinotecan—colon cancer	0.000383	0.000863	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Irinotecan—colon cancer	0.000383	0.000863	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Fluorouracil—colon cancer	0.000382	0.000861	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Capecitabine—colon cancer	0.000382	0.00086	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Methotrexate—colon cancer	0.000378	0.000853	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Methotrexate—colon cancer	0.000378	0.000853	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Methotrexate—colon cancer	0.000378	0.000853	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Methotrexate—colon cancer	0.000377	0.00085	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Capecitabine—colon cancer	0.000372	0.000838	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Methotrexate—colon cancer	0.000369	0.000831	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Capecitabine—colon cancer	0.000368	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Fluorouracil—colon cancer	0.000368	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Capecitabine—colon cancer	0.000367	0.000827	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Fluorouracil—colon cancer	0.000367	0.000826	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Vincristine—colon cancer	0.000366	0.000826	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Methotrexate—colon cancer	0.000363	0.000817	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Capecitabine—colon cancer	0.000358	0.000807	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Methotrexate—colon cancer	0.000358	0.000806	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Methotrexate—colon cancer	0.000357	0.000804	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Capecitabine—colon cancer	0.000357	0.000804	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Irinotecan—colon cancer	0.000357	0.000804	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Vincristine—colon cancer	0.000357	0.000804	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Capecitabine—colon cancer	0.000356	0.000803	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Capecitabine—colon cancer	0.000351	0.000791	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Capecitabine—colon cancer	0.000349	0.000787	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Irinotecan—colon cancer	0.000347	0.000783	CcSEcCtD
Medroxyprogesterone Acetate—Hydrocortisone—ABCB1—colon cancer	0.000347	0.0921	CrCbGaD
Medroxyprogesterone Acetate—Hypersensitivity—Fluorouracil—colon cancer	0.000342	0.00077	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Methotrexate—colon cancer	0.000341	0.000769	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Vincristine—colon cancer	0.00034	0.000767	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Methotrexate—colon cancer	0.00034	0.000765	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Methotrexate—colon cancer	0.00034	0.000765	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Capecitabine—colon cancer	0.000338	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Capecitabine—colon cancer	0.000338	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Capecitabine—colon cancer	0.000338	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Methotrexate—colon cancer	0.000337	0.00076	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Capecitabine—colon cancer	0.000337	0.000759	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000336	0.000757	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—colon cancer	0.000335	0.000756	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Capecitabine—colon cancer	0.000334	0.000753	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—colon cancer	0.000333	0.00075	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Irinotecan—colon cancer	0.000331	0.000747	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Capecitabine—colon cancer	0.000331	0.000745	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Vincristine—colon cancer	0.000329	0.000741	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Fluorouracil—colon cancer	0.000328	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—colon cancer	0.000327	0.000738	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Capecitabine—colon cancer	0.000327	0.000736	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Capecitabine—colon cancer	0.000324	0.00073	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Capecitabine—colon cancer	0.000322	0.000726	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—colon cancer	0.000321	0.000724	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Irinotecan—colon cancer	0.00032	0.000722	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Capecitabine—colon cancer	0.000319	0.000719	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Capecitabine—colon cancer	0.000318	0.000716	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—colon cancer	0.000317	0.000715	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Fluorouracil—colon cancer	0.000317	0.000715	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Capecitabine—colon cancer	0.000317	0.000715	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—colon cancer	0.000317	0.000714	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Capecitabine—colon cancer	0.000316	0.000713	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Vincristine—colon cancer	0.000316	0.000712	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—colon cancer	0.000315	0.00071	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Capecitabine—colon cancer	0.000315	0.000709	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Vincristine—colon cancer	0.000313	0.000707	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Capecitabine—colon cancer	0.000313	0.000706	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Vincristine—colon cancer	0.000313	0.000706	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Vincristine—colon cancer	0.000311	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Capecitabine—colon cancer	0.000309	0.000696	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—colon cancer	0.000308	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Irinotecan—colon cancer	0.000308	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—colon cancer	0.000307	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Fluorouracil—colon cancer	0.000307	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—colon cancer	0.000306	0.00069	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Irinotecan—colon cancer	0.000305	0.000688	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Irinotecan—colon cancer	0.000305	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—colon cancer	0.000305	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Irinotecan—colon cancer	0.000303	0.000684	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Capecitabine—colon cancer	0.000303	0.000683	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—colon cancer	0.0003	0.000676	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—colon cancer	0.000297	0.00067	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Methotrexate—colon cancer	0.000296	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—colon cancer	0.000296	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Vincristine—colon cancer	0.000295	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000295	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Fluorouracil—colon cancer	0.000295	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Capecitabine—colon cancer	0.000293	0.000661	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Fluorouracil—colon cancer	0.000292	0.000659	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Fluorouracil—colon cancer	0.000292	0.000658	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Capecitabine—colon cancer	0.000291	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Fluorouracil—colon cancer	0.000291	0.000655	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—colon cancer	0.000289	0.000652	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Capecitabine—colon cancer	0.000289	0.000651	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Irinotecan—colon cancer	0.000288	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—colon cancer	0.000286	0.000644	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Capecitabine—colon cancer	0.000285	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—ABCB1—colon cancer	0.000283	0.0751	CrCbGaD
Medroxyprogesterone Acetate—Decreased appetite—Capecitabine—colon cancer	0.000282	0.000635	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Capecitabine—colon cancer	0.00028	0.000631	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Capecitabine—colon cancer	0.000279	0.00063	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Capecitabine—colon cancer	0.000277	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Fluorouracil—colon cancer	0.000275	0.000621	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—colon cancer	0.000274	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—colon cancer	0.000273	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ABCB1—colon cancer	0.000267	0.071	CrCbGaD
Medroxyprogesterone Acetate—Feeling abnormal—Capecitabine—colon cancer	0.000267	0.000602	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—colon cancer	0.000267	0.000601	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—colon cancer	0.000266	0.000599	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Capecitabine—colon cancer	0.000265	0.000597	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Capecitabine—colon cancer	0.000257	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Capecitabine—colon cancer	0.000256	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Capecitabine—colon cancer	0.000256	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—colon cancer	0.000256	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—colon cancer	0.000252	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—colon cancer	0.000252	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—colon cancer	0.000252	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00025	0.000563	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—colon cancer	0.000249	0.00056	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000246	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ABCB1—colon cancer	0.000245	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—colon cancer	0.000243	0.000548	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—colon cancer	0.000241	0.000544	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000241	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—TYMS—colon cancer	0.00024	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—Infection—Methotrexate—colon cancer	0.00024	0.00054	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	0.000239	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000239	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Capecitabine—colon cancer	0.000239	0.000538	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—colon cancer	0.000239	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	0.000238	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000237	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—colon cancer	0.000237	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—colon cancer	0.000236	0.000532	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	0.000236	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—colon cancer	0.000234	0.000528	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000233	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—colon cancer	0.000233	0.000526	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000233	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000233	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Capecitabine—colon cancer	0.000233	0.000524	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000231	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—colon cancer	0.00023	0.000518	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Capecitabine—colon cancer	0.000229	0.000517	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—colon cancer	0.000225	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—KRAS—colon cancer	0.000225	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000225	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Capecitabine—colon cancer	0.000222	0.0005	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00022	0.000495	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—colon cancer	0.000219	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—colon cancer	0.000218	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000217	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—colon cancer	0.000217	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AXIN2—colon cancer	0.000217	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—colon cancer	0.000215	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—colon cancer	0.000215	0.000485	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—colon cancer	0.000214	0.000483	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000214	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Capecitabine—colon cancer	0.000214	0.000483	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000214	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000213	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—colon cancer	0.000212	0.000479	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CA7—colon cancer	0.000212	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—colon cancer	0.00021	0.000473	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.000209	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000208	0.000469	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—colon cancer	0.000208	0.000469	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PIK3CA—colon cancer	0.000207	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Capecitabine—colon cancer	0.000206	0.000464	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Capecitabine—colon cancer	0.000204	0.000461	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Capecitabine—colon cancer	0.000204	0.00046	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000203	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Capecitabine—colon cancer	0.000203	0.000458	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—colon cancer	0.000199	0.000448	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000198	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—HRAS—colon cancer	0.000198	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000198	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.000198	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CTNNB1—colon cancer	0.000197	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—colon cancer	0.000197	0.000445	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—HNF4A—colon cancer	0.000196	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000193	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CDKN1A—colon cancer	0.000193	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Capecitabine—colon cancer	0.000192	0.000434	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—colon cancer	0.000192	0.000432	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—HRAS—colon cancer	0.000192	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000191	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—colon cancer	0.000191	0.00043	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—colon cancer	0.000191	0.00043	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.00019	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—AKT1—colon cancer	0.000189	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000189	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DLC1—colon cancer	0.000188	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000187	0.000994	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000187	0.000994	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000185	0.000984	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000184	0.000981	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000183	0.000972	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000179	0.000955	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—colon cancer	0.000178	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000178	0.000946	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000178	0.000945	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—PPARG—colon cancer	0.000177	0.000942	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LGR5—colon cancer	0.000177	0.000941	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000177	0.000941	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—AKT1—colon cancer	0.000175	0.00093	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—colon cancer	0.000173	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000173	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	0.000173	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000173	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CA7—colon cancer	0.000173	0.000919	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—colon cancer	0.000171	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000171	0.000907	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PPARG—colon cancer	0.00017	0.000905	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—AKT1—colon cancer	0.000169	0.0009	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000168	0.000895	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000165	0.000879	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—colon cancer	0.000165	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000165	0.000876	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000164	0.000874	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000162	0.000861	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.00016	0.000852	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—colon cancer	0.00016	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—colon cancer	0.000159	0.000848	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	0.000158	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000156	0.000832	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000155	0.000824	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000154	0.000822	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—NRAS—colon cancer	0.000154	0.000818	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000153	0.000816	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—colon cancer	0.000153	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000153	0.000813	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Methotrexate—colon cancer	0.000152	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—colon cancer	0.000152	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000151	0.000806	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Methotrexate—colon cancer	0.000151	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.00015	0.000799	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—HNF4A—colon cancer	0.00015	0.000796	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000149	0.000791	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000148	0.00079	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000147	0.000783	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000144	0.000766	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000144	0.000765	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Methotrexate—colon cancer	0.000143	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000143	0.000761	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000141	0.000749	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—colon cancer	0.00014	0.000745	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000137	0.000728	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—PPARG—colon cancer	0.000135	0.000718	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—colon cancer	0.000134	0.000712	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000133	0.000708	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000133	0.000708	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—KRAS—colon cancer	0.000132	0.000704	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000131	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.00013	0.00069	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.00013	0.000689	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ODC1—colon cancer	0.000129	0.000684	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CHST5—colon cancer	0.000129	0.000684	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000127	0.000677	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AXIN2—colon cancer	0.000127	0.000676	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000123	0.000657	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	0.000122	0.000647	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ABCB1—colon cancer	0.000121	0.000643	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000119	0.000635	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000119	0.000633	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TYMS—colon cancer	0.000119	0.000631	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000118	0.000629	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000117	0.000621	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HNF4A—colon cancer	0.000115	0.000613	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA7—colon cancer	0.000114	0.000606	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HNF4A—colon cancer	0.000113	0.000604	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—FGFR3—colon cancer	0.000113	0.000603	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—HRAS—colon cancer	0.000112	0.000598	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—EP300—colon cancer	0.000111	0.000592	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.00011	0.000586	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000107	0.000571	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ODC1—colon cancer	0.000105	0.000557	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CHST5—colon cancer	0.000105	0.000557	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APC—colon cancer	0.000104	0.000553	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—PPARG—colon cancer	0.000104	0.000553	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	0.000102	0.000545	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000101	0.000539	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MYC—colon cancer	0.000101	0.000537	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	9.98e-05	0.000531	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—AKT1—colon cancer	9.93e-05	0.000528	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.79e-05	0.000521	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BRAF—colon cancer	9.77e-05	0.00052	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.13e-05	0.000486	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PPARG—colon cancer	8.52e-05	0.000454	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PPARG—colon cancer	8.4e-05	0.000447	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.27e-05	0.00044	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PIK3CA—colon cancer	8.23e-05	0.000438	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGFR3—colon cancer	7.93e-05	0.000422	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—colon cancer	7.89e-05	0.00042	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MYC—colon cancer	7.69e-05	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APC—colon cancer	7.28e-05	0.000387	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CTNNB1—colon cancer	7.06e-05	0.000376	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDKN1A—colon cancer	6.9e-05	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ODC1—colon cancer	6.9e-05	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CHST5—colon cancer	6.9e-05	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BRAF—colon cancer	6.84e-05	0.000364	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—colon cancer	6.73e-05	0.000358	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—colon cancer	6.61e-05	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EP300—colon cancer	6.56e-05	0.000349	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—colon cancer	6.49e-05	0.000346	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SRC—colon cancer	6.38e-05	0.00034	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGFR3—colon cancer	6.25e-05	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NRAS—colon cancer	6.14e-05	0.000327	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—colon cancer	5.92e-05	0.000315	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—colon cancer	5.83e-05	0.00031	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APC—colon cancer	5.74e-05	0.000306	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—colon cancer	5.72e-05	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—colon cancer	5.71e-05	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—colon cancer	5.6e-05	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—EP300—colon cancer	5.5e-05	0.000293	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BRAF—colon cancer	5.4e-05	0.000287	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.31e-05	0.000282	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KRAS—colon cancer	5.29e-05	0.000281	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—colon cancer	5.13e-05	0.000273	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—colon cancer	5e-05	0.000266	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—colon cancer	4.99e-05	0.000266	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CTNNB1—colon cancer	4.95e-05	0.000263	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—colon cancer	4.93e-05	0.000262	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—colon cancer	4.86e-05	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CA—colon cancer	4.86e-05	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDKN1A—colon cancer	4.83e-05	0.000257	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EP300—colon cancer	4.6e-05	0.000245	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—colon cancer	4.49e-05	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SRC—colon cancer	4.47e-05	0.000238	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—colon cancer	4.35e-05	0.000232	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.32e-05	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NRAS—colon cancer	4.3e-05	0.000229	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.17e-05	0.000222	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CA—colon cancer	4.07e-05	0.000216	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—colon cancer	4.05e-05	0.000215	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—colon cancer	4.01e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—colon cancer	4e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—colon cancer	3.97e-05	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—colon cancer	3.94e-05	0.00021	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—colon cancer	3.92e-05	0.000208	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CTNNB1—colon cancer	3.9e-05	0.000208	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDKN1A—colon cancer	3.81e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—colon cancer	3.7e-05	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KRAS—colon cancer	3.7e-05	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGFR3—colon cancer	3.67e-05	0.000195	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EP300—colon cancer	3.63e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SRC—colon cancer	3.53e-05	0.000188	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.47e-05	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—colon cancer	3.43e-05	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CA—colon cancer	3.4e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.4e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCB1—colon cancer	3.4e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NRAS—colon cancer	3.39e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APC—colon cancer	3.37e-05	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—colon cancer	3.37e-05	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TYMS—colon cancer	3.34e-05	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—colon cancer	3.32e-05	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—colon cancer	3.29e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BRAF—colon cancer	3.17e-05	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—colon cancer	3.16e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—colon cancer	3.15e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—colon cancer	3.15e-05	0.000167	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—colon cancer	3.09e-05	0.000164	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KRAS—colon cancer	2.92e-05	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—colon cancer	2.85e-05	0.000152	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.82e-05	0.00015	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—colon cancer	2.81e-05	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—colon cancer	2.78e-05	0.000148	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCB1—colon cancer	2.76e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TYMS—colon cancer	2.71e-05	0.000144	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CA—colon cancer	2.68e-05	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—colon cancer	2.6e-05	0.000138	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—colon cancer	2.57e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.57e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—colon cancer	2.48e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—colon cancer	2.38e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—colon cancer	2.36e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—colon cancer	2.31e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CTNNB1—colon cancer	2.29e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDKN1A—colon cancer	2.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—colon cancer	2.19e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EP300—colon cancer	2.13e-05	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.09e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SRC—colon cancer	2.07e-05	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—colon cancer	2.02e-05	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRAS—colon cancer	1.99e-05	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—colon cancer	1.98e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—colon cancer	1.95e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—colon cancer	1.92e-05	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—colon cancer	1.86e-05	9.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—colon cancer	1.85e-05	9.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—colon cancer	1.85e-05	9.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCB1—colon cancer	1.82e-05	9.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—colon cancer	1.81e-05	9.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TYMS—colon cancer	1.79e-05	9.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KRAS—colon cancer	1.71e-05	9.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CA—colon cancer	1.57e-05	8.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—EP300—colon cancer	1.55e-05	8.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—colon cancer	1.52e-05	8.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—colon cancer	1.51e-05	8.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—colon cancer	1.46e-05	7.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—colon cancer	1.29e-05	6.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—colon cancer	1.27e-05	6.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—EP300—colon cancer	1.26e-05	6.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CA—colon cancer	1.14e-05	6.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—colon cancer	9.98e-06	5.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—colon cancer	9.34e-06	4.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CA—colon cancer	9.31e-06	4.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—EP300—colon cancer	8.3e-06	4.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—colon cancer	7.6e-06	4.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CA—colon cancer	6.14e-06	3.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—colon cancer	5.01e-06	2.67e-05	CbGpPWpGaD
